MétaCan
Menu
Back to cohort
Record W2045872002 · doi:10.1093/eurheartj/ehv150

The role of heart rate may differ according to pathophysiological setting: from SHIFT to SIGNIFY

2015· article· en· W2045872002 on OpenAlexaboutno aff
Roberto Ferrari, Kim Fox

Bibliographic record

VenueEuropean Heart Journal · 2015
Typearticle
Languageen
FieldMedicine
TopicHeart rate and cardiovascular health
Canadian institutionsnot available
FundersNational Institute for Health and Care Research
KeywordsMedicinePathophysiologyCardiologyInternal medicine

Abstract

fetched live from OpenAlex

The results of the SIGNIFY (study assessing the morbidity–mortality benefits of the If inhibitor ivabradine in patients with coronary artery disease) trial, which were recently published in the New England Journal of Medicine,1 raise an important pathophysiological question regarding the relationship between elevated heart rate and outcomes in cardiovascular disease. Why did heart rate reduction with ivabradine improve prognosis in patients with chronic heart failure and left ventricular (LV) systolic dysfunction in the SHIFT (systolic heart failure treatment with the If inhibitor ivabradine trial) study,2 but not in patients with stable coronary artery disease (CAD) without heart failure and LV systolic dysfunction in SIGNIFY? The 19 102 patients recruited in SIGNIFY presented with stable CAD plus additional cardiovascular risk factors and resting heart rate ≥70 bpm.1 The SIGNIFY investigators deliberately recruited patients with no symptoms of heart failure or LV systolic dysfunction: the population had a mean left ventricular ejection fraction (LVEF) at baseline of 56.5 ± 8.6%.3 All were receiving guideline-based background therapy for their condition. In this stable CAD population, ivabradine had no effect on the primary endpoint, a composite of cardiovascular death or non-fatal myocardial infarction (MI), with annual event rates of 3.0% with ivabradine and 2.8% with placebo (hazard ratio [HR] 1.08, 95% confidence interval [CI], 0.96–1.20, P = 0.20).1 There were no significant differences between the groups in terms of any of the secondary endpoints including cardiovascular death (HR 1.10, P = 0.25), non-fatal MI (HR 1.04, P = 0.60), or all-cause death (HR 1.06, P = 0.35). Treatment with ivabradine was associated with an increase in primary composite endpoint in a sub-group of 12 049 patients with angina Canadian Cardiovascular Society (CCS) 2 and higher (63% of the whole population) vs. those on placebo (HR 1.18, P = 0.018, in patient with CCS class 2 angina or higher; P = 0.02 for interaction). There was no significant effect of ivabradine on the components of the primary endpoint or the main secondary endpoints in this angina population. There was no interaction between the use of ivabradine and outcomes in seven other pre-specified sub-groups, which were defined according to age, β-blocker use at baseline, sex, heart rate at baseline, history of diabetes, previous MI, or previous coronary revascularization.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.009
metaresearch head score (Gemma)0.029
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.009
Threshold uncertainty score0.048

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0090.029
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0030.002
Bibliometrics0.0010.001
Science and technology studies0.0000.002
Scholarly communication0.0020.002
Open science0.0020.003
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0070.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.048
GPT teacher head0.316
Teacher spread0.267 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations18
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Heart JournalSame topicHeart rate and cardiovascular healthFrench-language works237,207